Overview

Study of Glycopyrronium in Axillary Hyperhydrosis

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

The study is a randomized, double-blind, vehicle controlled, parallel group study, designed to assess the efficacy and safety of glycopyrronium topical wipes, once daily, compared to vehicle in subjects with axillary hyperhidrosis.

Phase:

Phase 3

Details

Lead Sponsor:

Dermira, Inc.
Journey Medical Corporation

Treatments:

Glycopyrrolate